PARLIAMENTARY WRITTEN QUESTION
Chronic Illnesses: Gene Therapies (1 March 2021)

To ask the Secretary of State for Health and Social Care, what assessment he has made of future routes to market for gene therapies with regard to the potential transformative effect of those one-off therapeutics for the treatment of chronic disease.

Asked by:
Bob Blackman (Conservative)

NHS England and NHS Improvement published the ‘NHS commercial framework for new medicines’ on 23 February 2021. The framework sets out the routes to commissioning for medicines and states that the main route for commissioning medicines, which includes gene and cell therapies, is expected to be through a National Institute for Health and Care Excellence (NICE) appraisal. The framework also sets out the commercial options that may be available to companies that NHS England and NHS Improvement and NICE may pursue in particular circumstances.

Answered by:
Jo Churchill (Conservative)
9 March 2021